News | Breast Imaging | May 19, 2016

Breast localization and surgical guidance system given peer-selected award for greatest scientific impact on breast cancer care

Cianna Medical, Savi Scout breast localization and surgical guidance system, American Society of Breast Surgeons, Scientific Impact Award

May 19, 2016 — Cianna Medical Inc. recently announced receipt of the 2016 Scientific Impact Award at the Society of Breast Surgeons (ASBrS) Annual Meeting for data presented validating the clinical utility of Savi Scout breast localization and surgical guidance system. The Scientific Impact Award is given to the clinical research presentation that is considered to have the greatest scientific impact on breast cancer care, as judged by surgeon attendees.

Scout, a U.S. Food and Drug Administration (FDA)-cleared breast lesion localization tool that uses micro-impulse radar to localize and direct the removal of non-palpable breast lesions, became available in late 2015. The technology has been rapidly adopted by physicians and is now in use at more than 50 medical centers across the United States.

Based on a separate research report, U.S.-based hospital executives have changed how they think about cost containment and are focusing their efforts on maximizing performance against quality metrics and driving operational efficiency.  It has also been reported that nearly 40 percent of all healthcare providers are willing to shift toward technologically advanced options for breast lesion localization that do not require invasive wires or radiation and have been shown to improve patient care.

The data presented during ASBrS showed that Scout achieved 100 percent surgical success, high clinical reproducibility, and favorable physician and patient satisfaction. Additionally, 97 percent of patients in the study would recommend SCOUT to other women.

The presentation on Scout was made by Nashville-based breast surgeon Pat Whitworth, M.D.  He accepted the award on behalf of Charles Cox, M.D., the Tampa, Fla.-based lead study investigator, himself and the other clinical study investigators. Whitworth is a breast surgical oncologist and director of the Nashville Breast Center. Cox is professor of surgery and McCann Foundation Endowed Professor of Breast Surgery, University of South Florida College of Medicine, director of The University of South Florida Breast Health Program and medical director of Morsani Ambulatory Surgery Center.

The Scout system features micro-impulse radar to detect a reflector that is placed at the tumor site up to seven days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the Scout handpiece, which emits infrared light and a micro-impulse signal to detect the location of the reflector. Real-time audible and visual indicators assist the surgeon in accurately locating the reflector, along with the target tissue. This higher level of localization precision allows the surgeon to plan a surgical approach that may result in a better cosmetic outcome.

For more information: www.ciannamedical.com


Related Content

News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
News | Breast Imaging

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...

Time October 28, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now